Biotech Stocks See Major Selling Pressure
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/18/2026
- Wall St ends lower for the day and week as chip selloff broadens
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Why the Fed may still need to hike rates
- Assassin's Creed Black Flag Resynced sells 3M copies in a week
- Magnitude 7.4 earthquake strikes coast of Chiapas, Mexico; Tsunami waves are possible
- Magnitude 7.4 earthquake strikes Puerto Madero, Mexico, USGS says
- Adobe has received a takeover approach by a Big Tech company - Betaville
- Wall St ends lower for the day and week as chip selloff broadens
UPDATE: BMO Capital Upgrades Biogen (BIIB) to Outperform
March 6, 2014 6:38 AM EST(Updated - March 6, 2014 12:10 PM EST)
BMO Capital upgraded Biogen (NASDAQ: BIIB) from Market Perform to Outperform with a price target of $422. Analyst Jim Birchenough, M.D. sees too many transformational opportunities to ignore.
The firm conducted an extensive pipeline review, and updated their financial model to reflect nearer-term opportunities for new product growth with ELOCTATE and... More
